- €27.12m
- €30.97m
- €21.11m
- 21
- 20
- 49
- 18
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16.7 | 18.2 | 17.8 | 16.2 | 21.1 |
Cost of Revenue | |||||
Gross Profit | 4.56 | 5.19 | 5.37 | 5.51 | 7.41 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 42.5 | 22.4 | 22 | 21.1 | 23 |
Operating Profit | -25.9 | -4.17 | -4.22 | -4.83 | -1.92 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.4 | -4.5 | -4.6 | -5.53 | -2.51 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.5 | -4.95 | -4.73 | -5.57 | -2.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -25.3 | -4.85 | -4.78 | -5.63 | -2.09 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.3 | -4.85 | -4.78 | -5.63 | -2.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.01 | -0.003 | -0.002 | -0.002 | 0 |